Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Celldex Therapeutics buy Stifel Nicolaus

Celldex Therapeutics
Start price
€26.00
26.02.26 / 50%
Target price
€57.53
26.02.27
Performance (%)
46.88%
Price
?
08:03
Summary
This prediction is currently active. With a performance of 46.88% the BUY prediction by Stifel_Nicolaus is a big success. This prediction currently runs until 26.02.27. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Celldex Therapeutics 13.561% 13.561%
iShares Core DAX® 0.625% 4.952%
iShares Nasdaq 100 1.160% -1.160%
iShares Nikkei 225® 2.356% -1.354%
iShares S&P 500 0.631% 1.380%

Comments by Stifel_Nicolaus for this prediction

In the thread Celldex Therapeutics diskutieren
Prediction Buy
Perf. (%) 46.88%
Target price 57.535
Change
Ends at 26.02.27

Celldex Therapeutics (CLDX) had its "buy" rating reaffirmed by Stifel Nicolaus. They now have a $68.00 price target on the stock, up from $58.00.
Ratings data for CLDX provided by MarketBeat

Stifel Nicolaus 
0
Report Share
26.02.26

Stopped prediction by Stifel_Nicolaus for Celldex Therapeutics

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€33.20
18.06.24
€54.03
18.06.25
-45.18%
19.06.25

Stifel Nicolaus 
18.06.24 50%